News
FDA approves first gene replacement therapy for SMA available to all ages
WHO Cancer R&D Report: Imbalances and Gaps in Clinical Research
Pharmaceutical markets of the CIS countries: results of July 2025 (according to IQVIA)
Rare Disease Evidence Principles (RDEP) - new FDA principles for evaluating orphan drugs